Aim: To analyse the increasing burden of coronary artery disease (CAD) in tropical and subtropical belts of the Equator since it remains blurred and carries a grim prognosis. Introduction: Endomyocardial fibrosis [EMF] is a tropical febrile disorder, confined to peculiar and limited geographical areas. Plaque buildup in endocardium and coronary arteries, causing ischemic injury and arrhythmic episodes, is a vanishing mystery in its pathogenesis and emphasizing alternative routes for understanding and treatment of this enigmatic disease. Case Report: 15 cases in various age groups were reported with potential complications of coronary artery disease and arrhythmias, associated with endocardial lesions, the characteristic feature of endomyocardial fibrosis. Conclusion: The narrowing of coronary arteries as a result of thickening of the walls, spasm, inflammation, plaques and its rupture produce ischemic episodes which can occur slowly or suddenly in a devastating pattern with arrhythmogenic potentials. The important steps to prevent and decrease the risk of CAD is to reduce the chance of getting this disorder by epidemiological measures with an advice of blood thinning medications such as small daily dose aspirin, antibiotics in susceptible individuals and revascularization in established myocardial infarction.
Introduction
Coronary artery disease (CAD) remains the most common etiology for high morbidity and mortality worldwide. The worldwide burden is set to reach 47 million affected individuals by the year 2020 as projected by World Health Organization (WHO) [1] . The understanding of pathophysiology of coronary artery disease had led to a decrease in the mortality towards the turn of the 20 th century [2] . There has been a greater focus in research aimed at all aspects of CAD in the last decade. The INTERHEART-South Asia study identified that the risk factors like abdominal obesity, smoking, hypertension, diabetes, psychosocial factors and lack of physical activity are more in urban areas and contribute for 89% of acute myocardial infarction in Indians.
The rising incidence of CAD is a new phenomenon in developing countries.
Several Western studies have demonstrated a significant role of various nutrients like fat, saturated fat and cholesterol in the causation of CAD [3] [4] . In contrast, the traditional Indian diet is low in fat content and, therefore cannot be the sole cause for the high prevalence of CAD in Indians. The findings of genome-wide association studies provide insights on the genetic architecture of coronary artery disease and the first common susceptible locus for CAD was identified at 9p21 [5] . Among the modifiable risk factors, consumption of coconut and its oil contain high amount of saturated fat, thought to be highly atherogenic, but a recent study states that there is no specific role of coconut in the causation of CAD [6] .
Recently, an increase in the incidence of CAD was reported from southern states of India and other etiologies, the infectious or inflammatory conditions such as Endomyocardial fibrosis may provide an insight in its analysis and so these cases had been reported. A 42 years old male was admitted with sudden onset of chest discomfort for 3 hours duration. ECG revealed acute anterior wall infarction as shown in Figure   8 . The patient was thrombolysed with streptokinase and further treated with anticoagulants, nitrates, antiplatelets and statins for 5 days. The patient remains Figure 2 . Showing the reverted sinus rhythm with 6 mg intravenous adenosine and a QS pattern in V 1 -V 4 , suggesting an old anterior myocardial infarction.
Case Reports
symptom free and echocardiography revealed RV (right ventricle) apical fibrosis as in Figure 9 and hypokinesia of interventricular septum as shown in Figure   10 . The patient was referred for revascularization procedures.
Case 4.
A 4-year-old female child was referred for cardiac evaluation since her pulse rate was <60 bpm. ECG revealed complete heart block as shown in Figure 11 and it was initially thought of congenital in origin, but echocardiography revealed a plaque like lesion in right ventricular apex as in Figure 12 . The child was treated with cefotaxime 250 mg three times daily for one week and the heart rate seemed to be increased as in Figure 13 . The child was advised further follow up with a continuation of tablet deriphyllin 100 mg daily to increase the heart rate. A 15-year-old female was presented with anginal episodes with ECG changes of T-inversion in V 1 -V 3 and echocardiography revealed apical fibrosis in right ventricle suggesting EMF as in Figure 14 . She was on nitrates, antiplatelet agents, statins and azithromycin 500mg weekly.
Case 6-showing plaque like lesions in IVS (interventricular septum) with ST-T changes in a 78-year-old female as shown in Figure 15 and advised nitrates, antiplatelet agents, statins and azithromycin 500 mg weekly.
Case 7. A 60-year-old male presented with acute myocardial infarction and echocardiography revealed IVS (interventricular) calcification as in Figure 16 and revasculaized with PCI (percutaneous coronary intervention).
Case 8. 52-year-old male presented with anginal episodes and echocardiography revealed finger-like projections of LV myocardium as in Figure 17 . The patient was advised blood-thinning medications (low dose aspirin 75 mg daily), statins and nitrates.
Case 9. A 60-year-old female was admitted with sudden onset of tachycardia and echocardiography revealed "egg-shell" calcification of right ventricular myocardium as in Figure 18 . The patient was treated with verapamil 40 mg 
Discussion

Review of Literature
It is interesting to note that almost 57 years ago, Allan Charters described a high Figure 11 . ECG showing complete heart block (heart rate 50 bpm) in a 4 -year old female child.
incidence of coronary artery disease among expatriate Indians in Kenya and he believed that the ingestion of animal fat was not an important etiological factor [7] [8]. Virchow, first proposed an association between infection and IHD (ischemic heart disease) > 100 years ago. Cardiotropic viruses were first implicated in the pathogenesis of CAD in 1968 when experimental Coxsackie B 4 virus infection in mice was shown to produce acute coronary arteritis [9] . Other investigators suggest a link between Coxsackie B virus and coronary artery disease, following a report of myocardial infarction, occurring in two normolipidemic male patients due to an unknown viral illness [10] .
Etiopathogenesis
Atherosclerosis is the main pathological process involved in CAD and it provides the first hints of potential infectious cause, with its characteristic inflammatory cell infiltrate in the lipid streaks seen in some children and young adults. Recent febrile illness has been associated significantly with myocardial infarction [16] . The individuals having seropositive for C. pnemoniae and H. pylori,
shown to possess elevated levels of fibrinogen, a risk factor for CAD. C-reactive protein (CRP), an another acute-phase protein, when present at levels approaching the upper limit of normal, is an indirect evidence of CAD [17] and correlate with poor prognosis in unstable angina [18] . However, high levels of acute-phase proteins mean inflammation, but chronically stressed myocardium may also induce an acute inflammatory response. blood vessels, serous cavities and it is immunologically mediated similar to rheumatic process, sometimes coexist in the same individual as in Figure 24 and The acute phase of Endomyocardial fibrosis (EMF), characterized by generalized allergic/immunological features, starts with a febrile illness associated with "pancarditis" or "myopericarditis", dyspnea, itching, uticaria, abdominal distension, facial or periorbital swelling (unilateral periorbital swelling (Romanas sign Case Reports in Clinical Medicine [22] results in myocardial damage, vasculitis with ECG changes of ischemia [23] , infarction, conduction disturbances, atrial or ventricular arrhythmias [24] and atrial fibrillation occurs in >30% of cases [25] . This acute phase of EMF is poorly understood, incompletely described and its clinical distinction from rheumatic Case Reports in Clinical Medicine fever in endemic areas can be challenging [26] . The active phase with recurrent flare-up of inflammation due to repeated insults GAS (Group A β hemolytic streptococci) exposure to RHD (rheumatic heart disease), unclear for EMF evolving to a chronic phase of cardiac manifestations. Endocardial thickening is the hallmark of EMF, which corresponds microscopically to an increased number and abnormal stimulation of cardiac fibroblasts in the subendocardium leading to increased collagen synthesis. Inflammatory cell infiltrates composed mainly of lymphocytes are prevalent along the interface between the endocardium and myocardium. Myocardial lesions such as interstitial fibrosis and scar formation are prominent in areas adjacent to subendocardial fibrosis and altered blood vessels, suggesting that they likely occur in response to ischemic injury caused by microvascular changes and there is a lack of vessels in the outer endocardium, in contrast to rheumatic heart disease.
Endomyocardial fibrosis is a multisystem disorder and it also affects the reproductive system, manifested as loss of secondary sexual characters, testicular atrophy, fibrosis of fimbrial ends of fallopian tube, leading to dysfunctional uterine bleeding and infertility as in Case 11, associated with IAS (interatrial septum) calcification. Poor genital hygiene and genital infections play an important role in the causation of EMF in endemic areas. EMF also involve the renalsystem and causes renal failure, occasionally presents with seizures as the initial manifestation with endocardial lesions in cardiac chambers.
Echocardiographic Features
Echocardiography has become the mainstay of diagnosis of EMF [27] . It has been used as the screening tool at the community level as the diagnosis of EMF can be confirmed at bedside.
In acute cases of EMF, the endocardial lesions are covered with a soft, spongy, greyish-green layer of thrombus as shown in Figure 23 . Large endocardial plaques are unique echocardiographic feature of EMF as in Figure 12 , Figure 14 , Figure 15 , Figure 19 and Figure 22 . EMF is marked by focal or diffuse areas of endocardial calcification, characterized by a white, smooth, and shiny endocardial surface as shown in Figure 9 and Figure 16 in interventricular septum (IVS), atrial septum as in Figure 20 and "egg-shell" calcification of myocardium as in Figure 3 and Figure 18 . The restricted movement of fibrotic ventricular apex and its obliteration are accompanied by compensatory contractile mechanism that results in exaggerated and distinctive motion of the basal portion of the ventricle, the so called "Merlon sign" [28] [29] .
In early stages of EMF, spontaneous contrast and abnormalities of ventricular regional wall motion [30] [31] . [32] may be observed as in Figure 4 and Figure 10 . The presence of a linear calcification, distal to the pericardium along the inner border of myocardium as in Figure 21 , enhanced density of moderator or other intraventricular bands suggests EMF and the occurrence of endomyocardial calcification spots as in Figure 7 is usually a marker of "burnt-out" disease [33] . The fibrotic lesions may be >1 cm thick and extend finger-like projections into the myocardium [34] as shown in Figure 17. 
Management
Medical Therapy
It has no specific treatment for EMF and carries poor prognosis since most patients present with advanced heart failure. Medical management consists of symptomatic treatment of heart failure with diuretics, angiotensin-converting enzyme inhibitors offered in combination with aspirin or anticoagulants in view of occurrence of coronary artery disease. The response to medical therapy is generally poor and unproven. When combined with rheumatic fever as evidenced by ASO (anti-streptolysin O) positivity, penicillin prophylaxis is a powerful modifier of the disease and causes regression when initiated early [35] in majority of cases.
Investigational Therapy
The fibrosis is a scarring process that over time impacts cardiac structure and function in Endomyocardial fibrosis. Therapies directed at cardiac fibrosis could reduce the progression of the disease. Medications that target the rennin-angiotensin system (RAS), transforming growth factor-β and endothelin (ET) are in various stages of development [36] . Biomarkers such as propeptides and telopeptides, released during synthesis and degradation of collagen type 1 and III of extracellular matrix (ECM) [37] , the structural component of myocardium, are used to identify fibrosis and to assess the efficacy of medications [38] .
RAS Inhibitors
The renin-angiotensin (RAS) system plays a central role in fibroblast activation and it is an important target for drug therapy. It is a complex system with two counterbalancing axes. In addition to familiar ACE/Ang II/AT 1 axis, an ACE 2 /Ang-(1-7)/Mas receptor axis has been identified, which has antifibrogenic and antiproliferative effects in heart. Administration of Ang-(1-7) and overexpression of ACE 2 can reduce cardiac fibrosis in animal models [39] . The routine use of RAS inhibiting medications, the ACE inhibitors, angiotensin II receptor blockers (ARBs) and aldosterone antagonists in hypertensive patients have shown to reduce fibrosis in humans.
Vaccines with angiotensin II effects (RAS vaccine) effectively decreased cardiac fibrosis in immunized mice, Ang II signaling was inhibited, and anti-Ang II antibodies increased.
TGF-β Inhibitors
Pirfenidone and tranilast have profound effects in reducing fibrosis, but the liver 
ET Inhibitors
Bosentan has been demonstrated to inhibit ECM formation, decreased collagen synthesis and increase collagenase suppression [41] in animal models.
HDAC (Histone Deacetylase) Inhibitors
These agents have positive results in reducing cardiac fibrosis as well as Ang II receptor and TGF-β levels in animal models and promising future therapeutic targets [42] .
Ivabradine
It is an oral medication that provides selective heart rate reduction by inhibiting the f-channels of the sinoatrial node [43] . It effectively reduces the fibrosis, circulating Ang II and aldosterone levels in animal models.
Imatinib
Inhibition of the protein, FIPILI-PDGFR alpha P , a constitutively activated tyrosine kinase by imatinib is a potential therapeutic target for patients with early EMF [44] .
Novel Treatment Strategies 1) Stem cell therapy
Transplantation of a variety of stem cells following myocardial infarction has been demonstrated to decrease cardiac fibrosis and cardiac muscle apoptosis [45] . The rationale of therapy is to improve blood supply to the ischemic areas of heart and to promote cardiac cell regeneration by a direct or paracrine factors by stem cells [46] [47].
The stem cells studied in cardiovascular research ranged from bone marrow to adipose tissue to skeletal muscle stem cells. These cells could potentially face rejection and it is possible to reprogram adult cells and transform these into pluripotent cells (similar properties as embryonic stem cells), termed as "induced pluripotent stem cells", which can be auto-transplanted and therefore would not be rejected.
The bone marrow-derived monoclonal, mesenchymal stem cells are most readily available for transplantation in the body. Following injection of mononuclear stem cells in patients with myocardial infarction, there is improvement in LV ejection fraction within months [48] , improve exercise capacity, decrease in scar tissue and a reduction in mortality in a 5-year follow up [49] occurs.
The heart possesses cardiac stem cells that could be responsible for the intrinsic regeneration and turnover throughout adult life [50] and these cells are numerous in apices of the atrium and ventricles [51] when cell function is reduced [55] . Thus, stem cell therapy continues to be a promising treatment modality in both acute and chronic CAD.
2) Nanomedicine
Nanotechnology has led to an interesting and promising direction in the treatment of coronary artery disease. HDL (high density lipoprotein) are thought to have a protective role since they are involved in the transportation of cholesterol away from the peripheral tissues. Nanotechnology has been used in the synthesis of a dimyristoyl phosphatidyl choline, which mimics the surface characteristics of HDL by mediating the removal of cholesterol from the peripheral tissue and transport it to the liver and this agent showed significant reduction in plaque volume and cholesterol content in aorta in animal models [56] .
Fumagillin is an antiangiogenic drug that has been shown to promote plaque regression in coronary vasculature, but causes neurocognitive effects at therapeutic effect in high doses.
Several nanoparticle-based antithrombotic agents such as D-phenylalanyl-
L-prolyl-Larginyl-Chloromethyl ketone, perfluorocarbon-core nanoparticle, collagen IV nanoparticles, which improve collagen formation while reducing oxidative stress by mimicking Annexin A 1 , a glucocorticoid regulatory protein in animal models [57] .
Molecular mimicry with genetic predisposition may result in autoimmune damage to endothelial lining of the heart and blood vessels, and treatment with nanobacteria is promising with reversal of calcific deposits within the vasculature.
3) During PCI (percutaneous coronary interventions)
Nanotechnology has shown potential benefits when used in PCI. It has the potential to promote healing by inducing endothelialization of the stent and to reduce restenosis [58] . Endothelial healing and re-endothelialization help to restore the injured vessel. Nano-sized hydroxyapatite coating, carbon nanoparticle coated stents with consistent release of sirolimus, pitavastatin nanoparticle-eluting stents [59] , Magnetic silica nanoparticles with rapamycin exhibit endothelialization in vitro-studies. It has been proven that liposome encapsulated alendronate (a biphosphonate) [60] , an antimitotic drug (paclitaxel) in the form of albumin-based nanoparticles with significant antiproliferative effects can reduce restenosis and neointimal hyperplasia in animal models, even when administered systemically [61] and to reduce platelet adhesion [62] . Gene eluting stents can be used to overcome restenosis, in-stent thrombosis and delayed endothelialization [63] . 
4) Novel oral anticoagulants
This group consists of ximelagatran, dabigatran, rivaroxaban, darexaban and apixaban [66] . Dabigatran is a competitive inhibitor of thrombin and the other agents, edoxaban, rivaroxaban and apixaban are inhibitors of clotting factor Xa.
Dabigatran reduces the ischemic events at higher doses (110 and 150 mg), which has a bleeding risk and low dose therapy could be used without significant increase in bleeding risk [67] .
5) Alirocumab
It is a monoclonal antibody produced by recombinant DNA technology, known to block the LDL regulator protein (PCSK9-Proprotein Convertase Subtilisin/Kexin Type 9), and reduce the LDL cholesterol to 66-73% when combined with atorvastatin, whereas atorvastatin alone cause reduction by 17% only [68] . and showed that it was ineffective at lower titers and favoured for patients with high titers (>1:512). These results raise the intriguing possibility that antibiotics might be selectively beneficial in a subgroup of patients with active infection, a more vigorous immune response or both. Treatment for bacteremia of unknown origin is problematic. Metronidazole is Case Reports in Clinical Medicine known to be effective for the treatment of anaerobic organisms and parasites. Additional metronidazole had improved outcome in STAMINA trial [77] when azithromycin is ineffective for Chlamydia Pneumoniae and complete eradication may take 1-year of treatment [78] (long-term therapy) since the organism is resistant to antibiotics when engulfed within the monocytes [79] . Leptospirosis (Weil's disease, first described by Adolf Weil in Heidelberg, Germany in 1886) is a zoonosis, caused by gram negative aerobic spirochete of the genus, leptospira interrogans and it is potentially pathogenic to humans (Leptospira biflexa is not), causing myocarditis and arrhythmic episodes [80] , 4 to 30 days after the initial phase (fever with rigors, jaundice, conjunctival suffusion, pharyngitis, muscle tenderness and rigidity). It is immunologically mediated and responds to antibiotics, the ceftriaxone, penicillin, ampicillin, azithromycin and doxycycline 200 mg/week is recommended in high risk areas.
Previous use of sulfonamides, macrolides, penicillin, cephalosporin had no effect on myocardial infarction (MI) risk and vancomycin may cause coronary artery spasm (Kounis syndrome) [81] .
Initiation of antibiotics with cefotaxime or amoxicillin provide better outcome in EMF patients in endemic areas. Once allergic stimulus was removed with small doses of chlorpheniramine maleate (avil) and dexamethasone (4mg), the ECG changes may become normalize at early stages of involvement and arrhythmic episodes reverse spontaneously or by specific treatment with adenosine, verapmil, amiodarone and cardioversion in resistant cases.
8) Pinocembrin
Pinocembrin is a major flavonoid derived from propolin, plays a role in the treatment of myocardial ischemia and reperfusion injury through its antioxidant effect, reduction of calcium overload, as well as inhibition of inflammation and myocardial cell apoptosis in animal models [82] . Pinocembrin exerts its antiarrhythmic effect by increasing the activity of Ca 2+ -Mg 2+ -ATPase, thereby maintaining cardiac channels and upregulating the expression of cardiomyocyte ligament junction proteins [83] ), the Cx43 (a gap junction protein, the main connexin of cardiomyocytes), ZO-1 (Claudin-1), Kir 2.1 and suppression of the redistribution of ZO-1 and Cx43, regulated by GJA 1 and KCNJ 2 genes to maintain the synchronization of electrical activity of the body and the development of heart [84] . 9) Levosimendan The clinically used inotropes worsen the reperfusion stunning and provoke arrhythmias by increasing the cytosolic calcium level. Levosimendan is a calcium sensitizer, which increases the myofilament calcium sensitivity without increasing myosin-ATPase activity. It is also a PDE (phosphodiesterase inhibitor) and K ATP channel opener, do not increase the cytosolic calcium when given in low concentrations. It protects the ischemic myocardium while at same time improving reperfusion mechanical function without elevating cytosolic calcium level and thus, it is a cardioprotective inotrope by virtue of its ATPase sparing and K ATP channel opening properties. It also induces changes in cAMP to cGMP ratio, an increase in cGMP level decrease the increase in cytosolic calcium during ischemia and protects from arrhythmic episodes [85] .
10) Antioxidants Direct induction of lipid peroxidation has arrhythmogenic effect on the heart. The stress affect the Na + , K + -ATPase activity and accelerates thermodenaturation of this enzyme which plays a key role in maintaining the transmembrane potential and electrical stability of the heart. Antioxidants prevent cardiac fibrillation during acute ischemia and reoxygenation of the heart [86] . 11) Surgical therapy Patients with end-stage EMF may not be suitable for surgery. Surgical management is mainly for relief of complications which are responsible for poor prognosis to medical therapy. Pericardio-peritoneal shunt for massive and recurrent pericardial effusion and in fewer cases, a right atrial to pulmonary arterial shunting and pericardial stripping may improve the outcome. In most cases, a clearly delineated cleavage plane allows for the removal of stiff, fibrotic endocardium (endocardiectomy) and improves the ventricular function, however, variable rates of recurrence after surgery have been reported [87] .
Outcome
EMF still causes significant morbidity in specific geographical pockets. Untreated EMF carries very poor prognosis and it represents the second leading cause of pediatric admissions for acquired heart disease after rheumatic heart disease [88] . The long-term outcome in medical treatment for advanced cases carries 75% mortality at 2 years [89] . An unknown number of cases evolve rapidly to heart failure and experienced sudden death caused by ventricular arrhythmias [90] .
Preventive Measures
EMF affects both indigenous and non-indigenous inhabitants, suggests that it is an environmental disease, caused by an infective agent, transmitted to the susceptible individual by a vector which is confined to the tropical and subtropical belts, especially in the hot, humid coastal areas and rain-forest regions. The disease affects the children and young adults in an epidemic fashion in tropical countries and it has remained poorly understood, not appearing in public health agenda of the countries [91] .
Investment in research is extremely limited. Improvement in environmental sanitation and hygienic measures may bring this neglected disease under control. Establishment of research stations and health care centers under the direct vision of WHO (World Health Organization) is mandatory in these tropical nations.
Case Analysis
The sociodemographic and clinical characteristics of patients are shown in Table   2 . 
Conclusion
Endomyocardial fibrosis (EMF) is characterized by extensive fibrosis with calcification and architectural distortion [92] of the heart. It is the disease of rural belts with a high prevalence in south India and appears to have regional variations in endemic countries [93] [94] . The changing pattern of coronary artery disease with characteristic epidemiologica features [95] in endemic areas provide the way to create alternate guidelines in the management of acute coronary syndrome and arrhythmogenic episodes in future.
